361 related articles for article (PubMed ID: 32372673)
21. Management of endocrine disease: GH excess: diagnosis and medical therapy.
Andersen M
Eur J Endocrinol; 2014 Jan; 170(1):R31-41. PubMed ID: 24144967
[TBL] [Abstract][Full Text] [Related]
22. T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly.
Potorac I; Petrossians P; Daly AF; Alexopoulou O; Borot S; Sahnoun-Fathallah M; Castinetti F; Devuyst F; Jaffrain-Rea ML; Briet C; Luca F; Lapoirie M; Zoicas F; Simoneau I; Diallo AM; Muhammad A; Kelestimur F; Nazzari E; Centeno RG; Webb SM; Nunes ML; Hana V; Pascal-Vigneron V; Ilovayskaya I; Nasybullina F; Achir S; Ferone D; Neggers SJ; Delemer B; Petit JM; Schöfl C; Raverot G; Goichot B; Rodien P; Corvilain B; Brue T; Schillo F; Tshibanda L; Maiter D; Bonneville JF; Beckers A
Endocr Relat Cancer; 2016 Nov; 23(11):871-881. PubMed ID: 27649724
[TBL] [Abstract][Full Text] [Related]
23. [Gigantism: a mystery explained].
Beckers A
Bull Mem Acad R Med Belg; 2002; 157(1-2):111-7; discussion 117-9. PubMed ID: 12371275
[TBL] [Abstract][Full Text] [Related]
24. [Acromegalogigantism].
Scheinmann P; Ducottet-Valdant MC; Meyer B; Luton JP; Paupe J; Vialatte J
Ann Pediatr (Paris); 1977 Apr; 24(4):287-91. PubMed ID: 16211971
[No Abstract] [Full Text] [Related]
25. Pegvisomant therapy in pituitary gigantism: successful treatment in a 12-year-old girl.
Rix M; Laurberg P; Hoejberg AS; Brock-Jacobsen B
Eur J Endocrinol; 2005 Aug; 153(2):195-201. PubMed ID: 16061823
[TBL] [Abstract][Full Text] [Related]
26. [Advances in the treatment of acromegaly].
Krysiak R; Okopień B; Marek B
Pol Merkur Lekarski; 2008 Jan; 24(139):59-65. PubMed ID: 18634256
[TBL] [Abstract][Full Text] [Related]
27. [Current diagnosis and treatment of acromegaly].
Melgar V; Espinosa E; Cuenca D; Valle V; Mercado M
Rev Med Inst Mex Seguro Soc; 2015; 53(1):74-83. PubMed ID: 25680646
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of long-acting pasireotide in Japanese patients with acromegaly or pituitary gigantism: results from a multicenter, open-label, randomized, phase 2 study.
Tahara S; Murakami M; Kaneko T; Shimatsu A
Endocr J; 2017 Jul; 64(7):735-747. PubMed ID: 28592706
[TBL] [Abstract][Full Text] [Related]
29. Modern approach to resistant acromegaly.
Giustina A; di Filippo L; Uygur MM; Frara S
Endocrine; 2023 May; 80(2):303-307. PubMed ID: 36790521
[TBL] [Abstract][Full Text] [Related]
30. Paradoxical GH Increase During OGTT Is Associated With First-Generation Somatostatin Analog Responsiveness in Acromegaly.
Scaroni C; Albiger N; Daniele A; Dassie F; Romualdi C; Vazza G; Regazzo D; Ferraù F; Barresi V; Maffeis V; Gardiman MP; Cannavò S; Maffei P; Ceccato F; Losa M; Occhi G
J Clin Endocrinol Metab; 2019 Mar; 104(3):856-862. PubMed ID: 30285115
[TBL] [Abstract][Full Text] [Related]
31. Molecular Characterization of Growth Hormone-producing Tumors in the GC Rat Model of Acromegaly.
Martín-Rodríguez JF; Muñoz-Bravo JL; Ibañez-Costa A; Fernandez-Maza L; Balcerzyk M; Leal-Campanario R; Luque RM; Castaño JP; Venegas-Moreno E; Soto-Moreno A; Leal-Cerro A; Cano DA
Sci Rep; 2015 Nov; 5():16298. PubMed ID: 26549306
[TBL] [Abstract][Full Text] [Related]
32. 6'6" United States Marine Seeks Treatment for Gynecomastia Only to Learn It Is All in His Head.
Young DB
Mil Med; 2015 Dec; 180(12):e1290-2. PubMed ID: 26633678
[TBL] [Abstract][Full Text] [Related]
33. Pituitary tumours: acromegaly.
Chanson P; Salenave S; Kamenicky P; Cazabat L; Young J
Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):555-74. PubMed ID: 19945023
[TBL] [Abstract][Full Text] [Related]
34. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly.
Schwyzer L; Starke RM; Jane JA; Oldfield EH
J Neurosurg; 2015 Apr; 122(4):798-802. PubMed ID: 25423276
[TBL] [Abstract][Full Text] [Related]
35. Acromegaly.
Dineen R; Stewart PM; Sherlock M
QJM; 2017 Jul; 110(7):411-420. PubMed ID: 26873451
[TBL] [Abstract][Full Text] [Related]
36. Ectopic GH-secreting pituitary adenoma of the clivus: systematic literature review of a challenging tumour.
Riccio L; Donofrio CA; Tomacelli G; De Blasi R; Melatini A
Pituitary; 2020 Aug; 23(4):457-466. PubMed ID: 32504302
[TBL] [Abstract][Full Text] [Related]
37. Acromegaly: clinical features at diagnosis.
Vilar L; Vilar CF; Lyra R; Lyra R; Naves LA
Pituitary; 2017 Feb; 20(1):22-32. PubMed ID: 27812777
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of pituitary gigantism.
Cunha C; Saraiva C; Canas Marques C; Duarte JS
BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34972788
[TBL] [Abstract][Full Text] [Related]
39. 'Silent' somatotropinoma.
Pawlikowski M; Kuta J; Fuss-Chmielewska J; Winczyk K
Endokrynol Pol; 2012; 63(2):88-91. PubMed ID: 22538745
[TBL] [Abstract][Full Text] [Related]
40. [Acromegaly and pregnancy: report of six new cases].
Persechini ML; Gennero I; Grunenwald S; Vezzosi D; Bennet A; Caron P
J Gynecol Obstet Biol Reprod (Paris); 2014 Nov; 43(9):704-12. PubMed ID: 24035359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
